Publications by authors named "Paolo Grassi"

Claim this Profile
S
Sevabertinib in Advanced -Mutant Non-Small-Cell Lung Cancer.
Xiuning Le, Tae Min Kim, Herbert H Loong, Arsela Prelaj, Boon Cher Goh, Paolo Grassi

N Engl J Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer.
Franziska Siegel, Stephan Siegel, Kristýna Kotýnková, Gizem Karsli Uzunbas, Daniel Korr, Paolo Grassi

Cancer Discov· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Translational Study Investigating Molecular PrEdictors of Resistance to First-Line PazopanIb in Metastatic reNal CEll Carcinoma (PIPELINE Study).
Pierangela Sepe, Antonia Martinetti, Alessia Mennitto, Elena Verzoni, Melanie Claps, Paolo Grassi

Am J Clin Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Conundrum of Septic Shock Imitators in Patients with Hematologic Cancers: Case Presentation and Possible Differential Diagnoses.
Giorgio Berlot, Giulia Moratelli, Martina Tarchini, Katiuscia Battaglia, Paolo Grassi

Case Rep Crit Care· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgery of locally advanced and metastatic kidney cancer after tyrosine kinase inhibitors therapy: single institute experience.
Alberto De Gobbi, Davide Biasoni, Mario Catanzaro, Nicola Nicolai, Luigi Piva, Paolo Grassi

Tumori· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TARIBO trial: targeted therapy with or without nephrectomy in metastatic renal cell carcinoma: liquid biopsy for biomarkers discovery.
Elena Verzoni, Raffaele Ratta, Paolo Grassi, Roberto Salvioni, Silvia Stagni

Tumori· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure to Multiple Lines of Treatment and Survival of Patients With Metastatic Renal Cell Carcinoma: A Real-world Analysis.
Raffaele Ratta, Elena Verzoni, Massimo Di Maio, Paolo Grassi, Maurizio Colecchia

Clin Genitourin Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal treatment of advanced renal cancer in 2017.
Alessia Mennitto, Elena Verzoni, Paolo Grassi, Raffaele Ratta, Giovanni Fucà

Expert Rev Clin Pharmacol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pure small cell recurrent prostate cancer developing syndrome of inappropriate antidiuretic hormone secretion.
Giorgia Peverelli, Paolo Grassi

Tumori· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Castration-naive metastatic prostate cancer: reshaping old paradigms.
Raffaele Ratta, Paolo Grassi, Giovanni Fucà, Elena Verzoni, Giuseppe Procopio

Expert Rev Anticancer Ther· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
Paolo Grassi, Elena Verzoni, Raffaele Ratta, Luca Porcu, Michele Prisciandaro

Drugs R D· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents.
Paolo Grassi, Ludovic Doucet, Palma Giglione, Viktor Grünwald, Bohuslav Melichar

Oncology· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy.
Paolo Grassi, Elena Verzoni, Raffaele Ratta, Alessia Mennitto, Filippo de Braud

Drug Des Devel Ther· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does F-18 FDG-PET still play a role in metastatic renal cell carcinoma?
Alessia Mennitto, Paolo Grassi, Elena Verzoni, Raffaele Ratta, Giuseppe Procopio

J Med Imaging Radiat Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What advances have been made in immune-therapy for renal cell carcinoma?
Elena Verzoni, Paolo Grassi, Raffaele Ratta

Future Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus treatment for neuroendocrine tumors: latest results and clinical potential.
Sara Pusceddu, Elena Verzoni, Natialie Prinzi, Alessia Mennitto, Daniela Femia, Paolo Grassi

Ther Adv Med Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib in advanced renal cell carcinoma: a METEOR impact on clinical practice.
Paolo Grassi, Elena Verzoni, Alessia Mennitto, Giuseppe Procopio

Transl Androl Urol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience.
Alessia Mennitto, Paolo Grassi, Raffaele Ratta, Elena Verzoni, Michele Prisciandaro

Ther Adv Urol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thromboelastographic predictors of venous thromboembolic events in critically ill patients: are we missing something?
Fabiana Tartamella, Michele C Vassallo, Giorgio Berlot, Paolo Grassi, Filippo Testa

Blood Coagul Fibrinolysis· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy advances in uro-genital malignancies.
Raffaele Ratta, Roberta Zappasodi, Daniele Raggi, Paolo Grassi, Elena Verzoni

Crit Rev Oncol Hematol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors.
Elena Verzoni, Paolo Grassi, Raffaele Ratta, Monica Niger, Filippo De Braud

Ther Adv Med Oncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis.
Paolo Grassi, Ludovic Doucet, Palma Giglione, Viktor Grünwald, Bohuslav Melichar

PLoS One· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant treatment for renal cell carcinoma: in the long run will we get the same answers?
Paolo Grassi, Elena Verzoni, Giuseppe Procopio

Expert Rev Anticancer Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study.
Elena Verzoni, Ugo De Giorgi, Lisa Derosa, Orazio Caffo, Francesco Boccardo, Paolo Grassi

Oncotarget· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Molecular Models: Where Are We Going?
Raffaele Ratta, Elena Verzoni, Paolo Grassi, Monica Niger, Giuseppe Procopio

EBioMedicine· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis